Respiri Past Earnings Performance
Past criteria checks 0/6
Respiri has been growing earnings at an average annual rate of 7.4%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 20.4% per year.
Key information
7.4%
Earnings growth rate
18.6%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | -20.4% |
| Return on equity | -270.4% |
| Net Margin | -686.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year
Nov 08
We're Keeping An Eye On Respiri's (ASX:RSH) Cash Burn Rate
Aug 17Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation
Apr 29Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation
Jan 03Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation
Sep 21We Think Respiri (ASX:RSH) Can Afford To Drive Business Growth
Jun 07Respiri (ASX:RSH) Is In A Good Position To Deliver On Growth Plans
Feb 22Revenue & Expenses Breakdown
How Respiri makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -7 | 8 | 0 |
| 31 Mar 24 | 1 | -7 | 7 | 0 |
| 31 Dec 23 | 1 | -6 | 7 | 0 |
| 30 Sep 23 | 1 | -6 | 6 | 0 |
| 30 Jun 23 | 1 | -6 | 6 | 0 |
| 31 Mar 23 | 1 | -6 | 6 | 1 |
| 31 Dec 22 | 1 | -6 | 5 | 1 |
| 30 Sep 22 | 1 | -6 | 5 | 1 |
| 30 Jun 22 | 1 | -7 | 6 | 1 |
| 31 Mar 22 | 1 | -7 | 6 | 1 |
| 31 Dec 21 | 1 | -8 | 7 | 1 |
| 30 Sep 21 | 1 | -9 | 8 | 1 |
| 30 Jun 21 | 1 | -11 | 10 | 1 |
| 31 Mar 21 | 1 | -12 | 11 | 1 |
| 31 Dec 20 | 1 | -12 | 12 | 1 |
| 30 Sep 20 | 2 | -10 | 9 | 2 |
| 30 Jun 20 | 2 | -7 | 7 | 2 |
| 31 Mar 20 | 2 | -7 | 6 | 3 |
| 31 Dec 19 | 2 | -7 | 5 | 4 |
| 30 Sep 19 | 2 | -8 | 5 | 4 |
| 30 Jun 19 | 1 | -8 | 5 | 4 |
| 31 Mar 19 | 1 | -7 | 4 | 4 |
| 31 Dec 18 | 1 | -6 | 3 | 4 |
| 30 Sep 18 | 1 | -4 | 3 | 3 |
| 30 Jun 18 | 1 | -3 | 2 | 2 |
| 31 Mar 18 | 1 | -2 | 2 | 1 |
| 31 Dec 17 | 2 | -1 | 2 | 1 |
| 30 Sep 17 | 1 | -2 | 2 | 1 |
| 30 Jun 17 | 1 | -3 | 2 | 1 |
| 31 Mar 17 | 1 | -3 | 2 | 1 |
| 31 Dec 16 | 1 | -3 | 2 | 1 |
| 30 Sep 16 | 1 | -4 | 2 | 1 |
| 30 Jun 16 | 1 | -4 | 2 | 1 |
| 31 Mar 16 | 0 | -5 | 2 | 2 |
| 31 Dec 15 | 0 | -5 | 1 | 3 |
| 30 Sep 15 | 0 | -5 | 2 | 3 |
| 30 Jun 15 | 0 | -5 | 2 | 3 |
| 31 Mar 15 | 0 | -6 | 3 | 3 |
| 31 Dec 14 | 0 | -6 | 4 | 3 |
| 30 Sep 14 | 0 | -8 | 6 | 3 |
| 30 Jun 14 | 0 | -10 | 7 | 4 |
| 31 Mar 14 | 0 | -10 | 7 | 4 |
| 31 Dec 13 | 0 | -10 | 7 | 3 |
Quality Earnings: RSH is currently unprofitable.
Growing Profit Margin: RSH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RSH is unprofitable, but has reduced losses over the past 5 years at a rate of 7.4% per year.
Accelerating Growth: Unable to compare RSH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RSH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: RSH has a negative Return on Equity (-270.36%), as it is currently unprofitable.